Bumper Offer - Urjas oil Just @ Rs. 1
Tazloc CT 6.25 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Tazloc CT 6.25 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Tazloc CT 6.25 Tablet. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Tazloc CT 6.25 Tablet include Dizziness, Nausea or vomiting, Back Pain. Some other side effects of Tazloc CT 6.25 Tablet have been listed ahead. These side effects of Tazloc CT 6.25 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Tazloc CT 6.25 Tablet has a Mild effect for pregnant women and Mild effect on lactating mothers. Warnings related to Tazloc CT 6.25 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Tazloc CT 6.25 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema, Hyperkalemia, Drug Allergy are examples of such conditions. The section on Tazloc CT 6.25 Tablet contraindications lists all such conditions.
Drug interactions for Tazloc CT 6.25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Tazloc CT 6.25 Tablet is not safe while driving, and is is not addictive in nature.
Tazloc CT 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tazloc CT 6.25 Tablet is used -
Severe
Mild
Common
Is the use of Tazloc CT 6.25 Tablet safe for pregnant women?
Tazloc CT rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Tazloc CT 6.25 Tablet safe during breastfeeding?
Tazloc CT may have very limited harmful effects for breastfeeding women.
What is the effect of Tazloc CT 6.25 Tablet on the Kidneys?
Very few cases of side effects of Tazloc CT on kidney have been reported.
What is the effect of Tazloc CT 6.25 Tablet on the Liver?
Side effects of Tazloc CT rarely affect the liver.
What is the effect of Tazloc CT 6.25 Tablet on the Heart?
Very few cases of side effects of Tazloc CT on the heart have been reported.
Tazloc CT 6.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Tazloc CT 6.25 Tablet unless your doctor advises you to do so -
Is this Tazloc CT 6.25 Tablet habit forming or addictive?
Forming a habit of Tazloc CT 6.25 Tablet has not been reported.
Interaction between Food and Tazloc CT 6.25 Tablet
Some foods when eaten with Tazloc CT 6.25 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Tazloc CT 6.25 Tablet
Consumption of alcohol and Tazloc CT 6.25 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
